NCT06362915View on ClinicalTrials.gov

Analgesic Effect of Illiohypogastic & Ilioinguinal Nerve Block in TAVR - TF (Prospective Randomized Study)

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

January 2, 2024

Primary Completion Date

July 15, 2024

Study Completion Date

August 30, 2024

Conditions
Anesthesia, Local
Interventions
DRUG

Lidocaine

* Group (A) lidocaine : will receive blind local infiltration in femoral region on the operation side by an experienced anesthesiologist using 20 ml lidocaine 1%.

DRUG

Bupivacain

• Group (B),bupivacaine: will receive ultrasound-guided ilioinguinal/iliohypogastric nerve block using 20 ml Bupivacaine 0.25% by an experienced anesthesiologist

Trial Locations (2)

11721

RECRUITING

maha sadek El Derh, Cairo

Unknown

RECRUITING

Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER